Journals / Medicine Science / 2018 / Cilt: 7 - Sayı: 4

The study of diazepam, pregabalin and glucose effect on glutamate toxicity: In vitro study

Pages
797–801
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to our data combination of diazepam, pregabalin and glucose are more effective than pure drug to reduce glutamate toxicity in cortex neuron culture.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study we used pregabalin, diazepam and glucose for evaluating which one are more effective agents against glutamate induced neurotoxicity.
📊
Key Findings & Data:After cortex culture preparation glutamate toxicity induced by adding 10-5 mM glutamate to each wells except negative control group.
💡
Conclusion & Impact:According to our data combination of diazepam, pregabalin and glucose are more effective than pure drug to reduce glutamate toxicity in cortex neuron culture.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

In this study we used pregabalin, diazepam and glucose for evaluating which one are more effective agents against glutamate induced neurotoxicity. After cortex culture preparation glutamate toxicity induced by adding 10-5 mM glutamate to each wells except negative control group. After 10 min different dose of diazepam, pregabalin and glucose were added for 24 h and then 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Total Antioxidant Status (TAC) and Total oxidant status (TOS) assays were done. Diazepam, dose dependently shows neuroprotective effects and low dose of diazepam did not increase cell viability higher than 80 %. Combination groups only in high dose increased neurons viability. Total Antioxidant capacity of Pregabalin also show correlation with diazepam groups and highest dose of both show nearest value to negative control group. In addition, lowest and highest oxidant level were gained by the negative and positive control groups respectively. Except high dose of combination group, all groups show statically difference in compare with the negative control group P<0,05. According to our data combination of diazepam, pregabalin and glucose are more effective than pure drug to reduce glutamate toxicity in cortex neuron culture.

🔖

Cite This Article

TAGHİZADEHGHALEHJOUGHİ, A., NALDAN, M. E. (2018). The study of diazepam, pregabalin and glucose effect on glutamate toxicity: In vitro study. Medicine Science, Cilt: 7 - Sayı: 4, 797–801. https://ajindex.com/articles/277612

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Plitman E, Nakajima S, de la Fuente-Sandoval C, et al. Glutamate-mediated excitotoxicity in schizophrenia: A review. Eur Neuropsychopharmacol. 2014;24:1591-605.
  2. Blacker CJ, Lewis CP, Frye MA, et al. Roles of metabotropic glutamate receptors (mGluRs) in bipolar disorder: a systematic review. Bipolar Disorders 2015; 17:124-5.
  3. Ramadan S, Lin A, Stanwell P. Glutamate and glutamine: a review of in vivo MRS in the human brain. NMR in Biomedicine. 2013;26:1630-46. Rousseaux CG. A Review of Glutamate Receptors II: Pathophysiology and Pathology. Journal of Toxicologic Pathology. 2008;21:133-73.
  4. Walker JE. Glutamate, Gaba, and Cns Disease - a Review. Neurochemical Research. 1983;8:521-50.
  5. Zavodnick AD, Ali R. N-acetylcysteine and metabotropic glutamate receptors: implications for the treatment of schizophrenia: a literature review. Psychiatric Quarterly. 2014;85:177-85.
  6. Balcar VJ, Takamoto A, Yoneda Y. Neurochemistry of L-glutamate transport in the CNS: A review of thirty years of progress. Collect. Czech. Chem. Commun. 2001;66:1315-40.
  7. Grados MA, Atkins EB, Kovacikova GI, et al. A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders. Psychol Res Behav Manag. 2015;8:115-31. Meldrum BS. Glutamate as a neurotransmitter in the brain: Review of physiology and pathology. J Nutr. 2000;130:1007s-15s. Mohler H. GABAA receptors in central nervous system disease: Anxiety, epilepsy, and insomnia. J Recept Signal Transduct Res. 2006;26:731-40.
  8. Brondino N, Fusar-Poli L, Panisi C, et al. Pharmacological modulation of gaba function in autism spectrum disorders: a systematic review of human studies. J Autism Dev Disord. 2016;46:825-39.
  9. Fabritius ML, Strom C, Koyuncu S, et al. Benefit and harm of pregabalin in acute pain treatment: a systematic review with meta-analyses and trial sequential analyses. Br J Anaesth. 2017;119:775-91.
  10. Generoso MB, Trevizol AP, Kasper S, et al. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis. Int Clin Psychopharmacol. 2017;32:49-55.
  11. Ryu JH, Lee PB, Kim JH, et al. Effects of pregabalin on the activity of glutamate transporter type 3. Br J Anaesth. 2012;109:234-9.
  12. Kumar N, Laferriere A, Yu JSC, et al. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem. 2010;113:552-61.
  13. Shimizu N, Tsuda M, Suzuki T, Misawa M. Role of metabotropic glutamate receptors in lowered seizure threshold of pentylenetetrazole during diaz